GPER1 and breast neoplasm: In a previous work, we have shown that the peptide ERα17p was able to reduce by ~50% the volume of subscapularis xenografted human breast tumors obtained from ERα−/GPER+ MDA-MB-231 basal B TNBC cells [79] in mice without apparently affecting the liver.